SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001509190-17-000024
Filing Date
2017-05-04
Accepted
2017-05-04 07:07:06
Documents
6
Period of Report
2017-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K petx-20170504x8k.htm 8-K 128511
2 EX-5.1 petx-20170504xex5_1.htm EX-5.1 31922
3 EX-10.1 petx-20170504xex10_1.htm EX-10.1 206282
4 EX-10.2 petx-20170504xex10_2.htm EX-10.2 346035
5 GRAPHIC petx-20170504xex5_1g001.jpg GRAPHIC 3933
6 GRAPHIC petx-20170504xex5_1g002.jpg GRAPHIC 49282
  Complete submission text file 0001509190-17-000024.txt   787665
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35952 | Film No.: 17811781
SIC: 2834 Pharmaceutical Preparations